Log in
Enquire now
‌

US Patent 6887466 Methods for selectively stimulating proliferation of T cells

Patent 6887466 was granted and assigned to Genetics Institute, Inc. on May, 2005 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
0
Current Assignee
‌
Genetics Institute, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
68874660
Patent Inventor Names
Carl H. June0
Craig B. Thompson0
Gary J. Nabel0
Gary S. Gray0
Paul D. Rennert0
Date of Patent
May 3, 2005
0
Patent Application Number
093502020
Date Filed
July 8, 1999
0
Patent Citations Received
‌
US Patent 12133867 Universal anti-CD22 chimeric antigen receptor engineered immune cells
0
‌
US Patent 12090147 Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0
‌
US Patent 12091681 Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
0
‌
US Patent 12091682 Methods for making, compositions comprising, and methods of using rejuvenated T cells
0
‌
US Patent 12104172 Processes for generating TIL products enriched for tumor antigen-specific t-cells
0
‌
US Patent 12109234 Anti-BCMA CAR T cell compositions
0
‌
US Patent 12121541 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 12122829 Human alpha-folate receptor chimeric antigen receptor
0
...
Patent Primary Examiner
‌
Phillip Gambel
0
Patent abstract

Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the accessory molecule are described. T cell proliferation occurs in the absence of exogenous growth factors or accessory cells. T cell activation is accomplished by stimulating the T cell receptor (TCR)/CD3 complex or the CD2 surface protein. To induce proliferation of an activated population T cells, an accessory molecule on the surface of the T cells, such as CD28, is stimulated with a ligand which binds the accessory molecule. The T cell population expanded by the method of the invention can be genetically transduced and used for immunotherapy or can be used in methods of diagnosis.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 6887466 Methods for selectively stimulating proliferation of T cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.